Literature DB >> 1082920

Control of t-lymphocyte and B-lymphocyte activation by two complementing Ir-GLphi immune response genes.

D H Katz, M E Dorf, B Benacerraf.   

Abstract

The possibility that the two complementing alpha- and beta-Ir-GLphi genes are independently responsible for controlling events in T lymphocytes and B lymphocytes, respectively, has been tested in double adoptive transfer experiments utilizing cells from appropriate inbred strains of mice. The results of these studies show that the functions of T lymphocytes and B lymphocytes and the cooperative interactions between T and B cells require the presence of both alpha- and beta-genes in each respective cell type. Moreover, evidence has been obtained in these studies that indicates a preference for the alpha- and beta-Ir-GLphi genes in the cis position to obtain the most effective T-B-cell interactions. The possible implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082920      PMCID: PMC2190165          DOI: 10.1084/jem.143.4.906

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions.

Authors:  D H Katz; T Hamaoka; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

2.  Antibody response in rats to the synthetic polypeptide (T,G)-A--L genetically linked to the major histocompatibility system.

Authors:  E Günther; E Rüde; O Stark
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

Review 3.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

Review 4.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

5.  Radioresistance of cooperative function of carrier-specific lymphocytes in antihapten antibody responses.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  Science       Date:  1970-10-23       Impact factor: 47.728

6.  Histocompatibility-linked immune-response genes in the rhesus monkey.

Authors:  M E Dorf; H Balner; M L de Groot; B Benacerraf
Journal:  Transplant Proc       Date:  1974-06       Impact factor: 1.066

7.  The allogeneic effect in inbred mice. II. Establishment of the cellular interactions required for enhancement of antibody production by the graft-versus-host reaction.

Authors:  D H Katz; D P Osborne
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

8.  Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

9.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

10.  Studies on hypersensitivity. IV. The relationship between contact and delayed sensitivity: a study of the specificity of cellular immune reactions.

Authors:  P G GELL; B BENACERRAF
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

View more
  13 in total

1.  Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion.

Authors:  R H Schwartz; C S David; M E Dorf; B Benacerraf; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

2.  Immune suppression in vivo with antigen-modified syngeneic cells. I. T-cell-mediated suppression to the terpolymer poly-(Glu, Lys, Phe)n.

Authors:  N K Cheung; D H Scherr; K M Heghinian; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

Review 3.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

4.  Expression of the I-E target antigen for T-cell killing requires two genes.

Authors:  K F Lindahl; B Hausmann
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  Antigenic modification, rosette-forming cells, and Salmonella typhimurium resistance in outbred and inbred mice.

Authors:  N J Bigley; D P Kreps; R A Smith; A Esa
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  The requirement for two complementing Ir-GLphi immune response genes in the T-lymphocyte proliferative response to poly-(Glu53Lys36Phe11).

Authors:  R H Schwartz; M E Dorf; B Benacerraf; W E Paul
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

7.  Role of the H-2 complex in induction of T helper cells in vivo. II Negative selection of discrete subgroups of T cells restricted by I-A and I-A/E determinants.

Authors:  J Sprent; B Alpert
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

8.  Inclusion group systems and cis-trans effects in responses controlled by the two complementing Ir-GLphi genes.

Authors:  M E Dorf; P H Maurer; F Merryman; B Benacerraf
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

9.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VII. Idiotype-specific suppression of plaque-forming cell responses.

Authors:  D H Sherr; S T Ju; J Z Weinberger; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

10.  Antigen-specific helper T cells required for dominant production of an idiotype (THId) are not under immune response (Ir) gene control.

Authors:  K Bottomly; P H Maurer
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.